Grant Private Wealth Management’s 10x Genomics TXG Stock Holding History

Grant Private Wealth Management’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$292K	Buy	+7,624	New	+$200K	0.12%	126
2026 Q1	–	Sell	-10,763	Closed	-$176K	–	161
2025 Q4	$176K	Sell	10,763 -1,290	-11%	-$19.5K	0.11%	133
2025 Q3	$141K	Buy	+12,053	New	+$157K	0.09%	141
2025 Q2	–	Sell	-13,638	Closed	-$119K	–	140
2025 Q1	$119K	Sell	13,638 -880	-6%	-$11.1K	0.13%	116
2024 Q4	$209K	Buy	+14,518	New	+$229K	0.23%	107

Other funds holding TXG

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

MCP

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

AWA

Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

EWM

Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

Grant Private Wealth Management's TXG Position: Q2 2026 in Review

Grant Private Wealth Management opened a new position in 10x Genomics (TXG) in Q2 2026: 7,624 shares worth $292K. The stake represents 0.12% of the portfolio and ranks #126 among its holdings. This is a return to the name: Grant Private Wealth Management previously reported a position in TXG as recently as Q4 2025.

Grant Private Wealth Management first reported a position in TXG in Q4 2024 and has held it in 5 quarters since. 30 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Grant Private Wealth Management held 7,624 shares of 10x Genomics worth $292K as of Q2 2026.
10x Genomics was a new Grant Private Wealth Management position in Q2 2026.
10x Genomics made up 0.12% of Grant Private Wealth Management's portfolio in Q2 2026, its #126 holding.
Grant Private Wealth Management first reported a position in 10x Genomics in Q4 2024 and has held it in 5 quarters since.
30 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Grant Private Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.